XXXX thank -- everybody Thanks, joining second Joe. to and the call. want Good everybody earnings morning, for I thank, quarter
thank I Before I would to the team InfuSystem. like at begin,
missed have revenue specifically on and the smoothly. to continue market to run taken haven't like beat and cycle I we teams. would significant our a as thank operations share We sales
in in sales The been share business, a for drive of team first XXXX revenue, of in resulting position flow. systems team new the revenue the EBITDA cycle us tremendous. that additive to to and during year a and growth practices half efforts sustained and The in cash the put continues execute through improved multiyear are strong on You earnings, market have XXXX. increases to collections upgrade and have continues
opportunities exactly Our like going as plan numbers. advantage to highlights market Schulte, to the through a of is Greg take couple gain in of planned. share I'd oncology our share CFO, walks before and
XX.X% of and additional saw The wins IPD At talk share discussed from elastomeric in starting that of result revenue growth management the that, our growth growth last late -- First, In elastomeric the year. time, in result quarter, to we revenue. believed about gains increase recently began InfuSystem we market the see strong that the strong we group we that plus in the and how our was program. to a are we would and second exit growth provider leading in pain that first completed XXXX. year-over-year exit market sales IPD the product
we share that second are is now exciting the of our market most What's gains. in phase
customers quarter first of the changed XXXX oncology, are taking we in on call, our discussed winning business full its As largest model competitor and has and new day. earnings advantage every
significant As see positive we'll revenue that even on future our an new business quarters, revenue. flows in process our cycle through impact and greater
we converting pleased growing, earnings. report just to we revenue that not am are into I Secondly, are
XX.X% of of $X.X in Our versus is second the increase adjusted which EBITDA XXXX. an QX was million quarter,
of EBITDA with our long-term net operating share a to As our improvement margins. goal grows XX% achieving maintain we discipline, our spending and see steady cost expect and control we margin in
I first, oncology, Greg second financials. review will quarter but will in the progress our add some color to